Not yet recruitingInterventionalNot ApplicableUpdated Apr 9, 2026
Subtenon Block Combined With General Anesthesia for Vitreoretinal Surgery | NCT02282774 | Trialant
CompletedInterventionalPhase 3Updated Nov 4, 2014
Subtenon Block Combined With General Anesthesia for Vitreoretinal Surgery
ClinicalTrials.gov ID
NCT02282774
Lead Sponsor
King Saud UniversityOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
80Actual
Last Update Posted
Nov 4, 2014Estimated
Start Date
Dec 2013
Primary Completion Date
Jun 2014Actual
Brief Summary
To evaluate the effects of subtenon block (SB) as an adjunct to general anaesthesia on postoperative pain, oculocardiac reflex and postoperative nausea and vomiting for vitreoretinal surgery.
Subtenon Anesthesia
2% lidocaine and 0.5% bupivacaine
Sham subtenon block
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient undergoing elective retinal surgery under general anesthesia
Exclusion Criteria:
ASA physical status > Grade II,
psychiatric conditions,
neurological impairment,
deafness with whom communication would be difficult in the postoperative period,
clotting abnormalities,
contraindications for regional anesthesia,
drug abuse,
history of allergy to the study drugs,
previous vitreoretinal or strabismus surgery,
endophthalmitis, or inflammatory eye pathology
taking analgesics, antiemetics or drugs that might affect hemodynamics
Primary Purpose
Supportive Care
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Double
No central contacts
There are no central contacts for this study.
King Abdulaziz University Hospital at King Saud University